Direkt zum Inhalt
Merck

Folic acid functionalized ZnO quantum dots for targeted cancer cell imaging.

Nanotechnology (2015-07-08)
Ying-Ying Ma, Hui Ding, Huan-Ming Xiong
ZUSAMMENFASSUNG

Aqueous stable luminescent ZnO quantum dots (QDs) were successfully synthesized with primary amine groups on the surface, which were designed to conjugate with folic acid (FA) to produce the final ZnO-FA QDs. Such ZnO-FA QDs were able to target some specific cancer cells with overexpressed FA receptors on the membranes and thus differentiate the MCF-7 cancer cells from the normal 293T cells. The nanoparticle uptaking experiments by different cells were carried out in parallel and tracked by confocal laser microscopy dynamically. The results confirmed the specificity of our ZnO-FA QDs towards the FA-receptor overexpressed cancer cells, which had potential for diagnosing cancers in vitro.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Thiazolylblau-Tetrazoliumbromid, 98%
Sigma-Aldrich
2,2′-Azobis(2-Methylpropionitril), 98%
Sigma-Aldrich
Thiazolylblau-Tetrazoliumbromid, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥97.5% (HPLC)
Sigma-Aldrich
Methacrylsäure, contains 250 ppm MEHQ as inhibitor, 99%
Sigma-Aldrich
Triethylenglycol, ReagentPlus®, 99%
Sigma-Aldrich
Triethylenglycol, BioUltra, anhydrous, ≥99.0% (GC)